IP Library Granted Patent US 11,413,460
Granted Patent B2
US 11,413,460 · App. 17/693,577 · Granted Aug 16, 2022

Method and apparatus for application of a neural stimulus

Inventors: John Louis Parker (Artarmon, AU); James Hamilton Wah (Artarmon, AU); Dean Michael Karantonis (Artarmon, AU); Milan Obradovic (Artarmon, AU); Robert Bruce Gorman (Artarmon, AU)
Assignee: Saluda Medical Pty Ltd
A61N1/36139A61N1/0551A61N1/36071A61N1/36167
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,413,460
App. No.
17/693,577
Granted
Aug 16, 2022
Kind
B2
Abstract

A method of applying a neural stimulus with an implanted electrode array involves applying a sequence of stimuli configured to yield a therapeutic effect while suppressing psychophysical side effects. The stimuli sequence is configured such that a first stimulus recruits a portion of the fibre population, and a second stimulus is delivered within the refractory period following the first stimulus and the second stimulus being configured to recruit a further portion of the fibre population. Using an electrode array and suitable relative timing of the stimuli, ascending or descending volleys of evoked responses can be selectively synchronised or desynchronised to give directional control over responses evoked.

Claims (30)

1. A method of suppressing pain by controlling a neural stimulus, the method comprising:

applying the neural stimulus to a neural pathway of a patient in order to evoke a neural compound action potential on the neural pathway, the stimulus being defined by a stimulus parameter;

measuring the neural compound action potential evoked by the stimulus,

deriving from the measured evoked neural compound action potential a feedback variable; and

completing a feedback loop for applying the neural stimulus by using the feedback variable to adjust the stimulus parameter,

wherein completing the feedback loop comprises:

determining an error signal based on a difference between the feedback variable and a set point;

scaling the error signal by a gain; and

determining a value for the stimulus parameter based on the scaled error signal.

2. The method of claim 1 , wherein the feedback variable is an amplitude measure of the evoked neural compound action potential.

3. The method of claim 1 , wherein the stimulus parameter is an amplitude of a stimulus current.

4. The method of claim 1 , wherein obtaining the value for the stimulus parameter comprises integrating the scaled error signal to obtain a value for the stimulus parameter.

5. The method of claim 1 , wherein obtaining the value for the stimulus parameter comprises adjusting the stimulus parameter by the scaled error signal.

6. An implantable device for suppressing pain by controllably applying a neural stimulus, the implantable device comprising:

a plurality of electrodes including one or more stimulus electrodes and one or more sense electrodes;

a stimulus source configured to provide a neural stimulus to be delivered from the one or more stimulus electrodes to a neural pathway of a patient to evoke a neural compound action potential on the neural pathway;

measurement circuitry for measuring the evoked neural compound action potential sensed at the one or more sense electrodes; and

a control unit configured to:

control the stimulus source to provide the neural stimulus according to a stimulus parameter;

measure via the measurement circuitry a neural compound action potential evoked by the stimulus;

determine from the measured evoked neural compound action potential a feedback variable; and

complete a feedback loop for applying the neural stimulus by using the feedback variable to adjust the stimulus parameter,

wherein the control unit is configured to complete the feedback loop by:

determining an error signal based on a difference between the feedback variable and a set point;

scaling the error signal by a gain; and

determining a value for the stimulus parameter based on the scaled error signal.

7. The implantable device of claim 6 , wherein the feedback variable is an amplitude measure of the evoked neural compound action potential.

8. The implantable device of claim 6 , wherein the stimulus parameter is an amplitude of a stimulus current.

9. The implantable device of claim 6 , wherein the control unit is configured to obtain the value for the stimulus parameter by integrating the scaled error signal to obtain a value for the stimulus parameter.

10. The implantable device of claim 6 , wherein the control unit is configured to obtain the value for the stimulus parameter by adjusting the stimulus parameter by the scaled error signal.

Assignments (4)
SECURITY INTEREST Recorded Mar 14, 2025
From: SALUDA MEDICAL PTY LTD
To: PERCEPTIVE CREDIT HOLDINGS IV, LP
Reel/Frame 070518/0710 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 22, 2022
From: PARKER, JOHN LOUIS; WAH, JAMES HAMILTON; KARANTONIS, DEAN MICHAEL; OBRADOVIC, MILAN; GORMAN, ROBERT BRUCE
To: SALUDA MEDICAL PTY LTD
Reel/Frame 059777/0758 →
CONFIRMATORY ASSIGNMENT Recorded Apr 22, 2022
From: NICTA IPR PTY LTD
To: SALUDA MEDICAL PTY LTD
Reel/Frame 059777/0829 →
CONFIRMATORY ASSIGNMENT Recorded Apr 22, 2022
From: NATIONAL ICT AUSTRALIA LTD
To: NICTA IPR PTY LTD
Reel/Frame 059778/0028 →
Priority Claims (2)
AU 2011901828 · May 13, 2011 · national
AU 2011901829 · May 13, 2011 · national
Continuity (10)
Continuation 17576060 · Jan 14, 2022
Continuation 17514650 · Oct 29, 2021
Continuation 17501823 · Oct 14, 2021
Continuation 17489710 · Sep 29, 2021
Continuation 17478793 · Sep 17, 2021
Continuation 17031749 · Sep 24, 2020
Continuation 15846069 · Dec 18, 2017
Continuation 14844929 · Sep 3, 2015
Continuation 14117586
Related Publication 20220193416A1 · Jun 23, 2022